NASDAQ: NEOG · Life Sciences · 5 alerts · CIK 711377
Share price
$10.88Close, Nov 16
Market cap
$2.38B
Shares outstanding
218.31MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Neogen Corp filings on SEC EDGAR ↗
Jeremy Yarwood, CSO, sold 9,051 shares of Neogen Corp at $12.67 a share, worth $115K in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).
Neogen Corporation provided a status update on the pending sale of its global Genomics business to Zoetis Inc. To facilitate regulatory clearance from the ACCC and NZCC, Zoetis has offered to divest certain assets in Australia, with the transaction now expected to close in early 2027.
Neogen Corporation's shareholders approved the Amended and Restated Omnibus Incentive Plan at the annual meeting held on October 1, 2026. The plan authorizes the issuance of up to 31,350,000 shares for various equity-based awards, including stock options and restricted stock units, for employees and non-employee directors. This filing amends a previous 8-K to specifically include the disclosure of this shareholder approval.